Revvity (RVTY) Cash & Current Investments (2009 - 2026)
Revvity's (RVTY) quarterly Cash & Current Investments came in at $860.3 million in Q2 2026, down 24.38% YoY from $1.1 billion in Q2 2025, and down 6.47% on a QoQ basis from $919.9 million in Q4 2025.
Revvity (RVTY) Cash & Current Investments (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Cash & Current Investments data on file, last reported at $860.3 million in Q2 2026.
- Quarterly Cash & Current Investments fell 24.38% year-over-year to $860.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $860.3 million (down 24.38% YoY) and the FY2025 annual result came in at $919.9 million, down 20.93% from the prior year.
- Cash & Current Investments slipped to $860.3 million in Q2 2026, from $919.9 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $2.5 billion in Q2 2023 to a low of $345.9 million in Q3 2022.
- A 5-year average of $1.2 billion and a median of $1.1 billion in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2023 — Cash & Current Investments soared 498.78% — and 2025, when it plunged 49.25%.
- Tracing RVTY's Cash & Current Investments over 5 years: stood at $400.7 million in 2022, then soared by 300.03% to $1.6 billion in 2023, then retreated by 27.43% to $1.2 billion in 2024, then declined by 20.93% to $919.9 million in 2025, then slipped by 6.47% to $860.3 million in 2026.
- The last three Cash & Current Investments figures came in at $860.3 million (Q2 2026), $919.9 million (Q4 2025), and $931.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 196.93 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 2.08 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.10 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.17 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 626.00 Mn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | 860.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 860.32 Mn |
| Dec 28, 2025 | 919.86 Mn |
| Sep 28, 2025 | 931.39 Mn |
| Jun 29, 2025 | 991.85 Mn |
| Mar 30, 2025 | 1.14 Bn |
| Dec 29, 2024 | 1.16 Bn |
| Sep 29, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.95 Bn |
| Mar 31, 2024 | 1.70 Bn |
| Dec 31, 2023 | 1.60 Bn |
| Oct 1, 2023 | 1.43 Bn |
| Jul 2, 2023 | 2.07 Bn |
| Apr 2, 2023 | 2.46 Bn |
| Jan 1, 2023 | 454.36 Mn |
| Oct 2, 2022 | 400.74 Mn |
| Jul 3, 2022 | 345.86 Mn |
| Apr 3, 2022 | 654.76 Mn |
| Jan 2, 2022 | 603.32 Mn |
| Oct 3, 2021 | 472.37 Mn |
| Jul 4, 2021 | 572.81 Mn |